Further studies would be needed to fully elucidate its mechanism of action.<h4>Conclusion</h4>NCBP-1 represents a promising lead for the development of novel antibacterial agents, particularly for treating Gram-negative bacterial infections. The gene discussed is NCBP1; the disease is gram-negative bacterial infections.